Tracon Pharmaceuticals Company Profile (NASDAQ:TCON)

About Tracon Pharmaceuticals

TRACON Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration (wet AMD) and fibrotic diseases. The Company's research focuses on antibodies that bind to the endoglin receptor, which is essential to angiogenesis (the process of new blood vessel formation) and a contributor to fibrosis (tissue scarring). The Company's lead product candidate, TRC105, is an endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor (VEGF) pathway. TRC205 is being developed for the treatment of fibrotic disease. The Company is also developing TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: TCON
CUSIP:

Key Metrics:

Previous Close: $6.55
50 Day Moving Average: $6.09
200 Day Moving Average: $6.19
52-Week Range: $4.00 - $12.50
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -3.06
P/E Growth: 0.00
Market Cap: $79.08M
Outstanding Shares: 12,203,000
Beta: 2.88

Profitability:

Net Margins: -703.77%
Return on Equity: -111.98%
Return on Assets: -65.14%

Debt:

Debt-to-Equity Ratio: 0.31%
Current Ratio: 2.85%
Quick Ratio: 2.85%

Additional Links:

Companies Related to Tracon Pharmaceuticals:

Consensus Ratings for Tracon Pharmaceuticals (NASDAQ:TCON) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$20.50 (212.98% upside)

Analysts' Ratings History for Tracon Pharmaceuticals (NASDAQ:TCON)

Show:

Date	Firm	Action	Rating	Price Target
8/19/2016	BTIG Research	Initiated Coverage	Buy	$15.00
2/1/2016	Oppenheimer Holdings Inc.	Reiterated Rating	Outperform
10/8/2015	Roth Capital	Reiterated Rating	Buy
3/2/2015	Stifel Nicolaus	Boost Price Target	Buy	$16.00 -> $20.00
2/24/2015	Wells Fargo & Co.	Initiated Coverage	Outperform
2/24/2015	Needham & Company LLC	Initiated Coverage	Buy	$19.00

(Data available from 9/30/2014 forward)

Earnings History for Tracon Pharmaceuticals (NASDAQ:TCON)

Date	Quarter	Consensus Estimate	Actual EPS	Actual Revenue	Release Link	Conference Call
11/1/2016
8/10/2016	Q2	($0.62)	($0.68)		View	Listen
5/11/2016	Q1	($0.70)	($0.54)		View	Listen
2/18/2016	Q4	($0.62)	($0.91)		View	Listen
11/3/2015	Q3	($0.51)	($0.53)		View	Listen
8/5/2015	Q215	($0.42)	($0.24)	$4.20 million	View	Listen
5/13/2015	Q1	($0.37)	($0.50)		View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Tracon Pharmaceuticals (NASDAQ:TCON)

Current Year EPS Consensus Estimate: $-2.38 EPS
Next Year EPS Consensus Estimate: $-2.14 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	1	($0.56)	($0.56)	($0.56)
Q2 2016	2	($0.70)	($0.46)	($0.58)
Q3 2016	2	($0.75)	($0.48)	($0.62)
Q4 2016	2	($0.85)	($0.50)	($0.68)

(Data provided by Zacks Investment Research)

Dividend History for Tracon Pharmaceuticals (NASDAQ:TCON)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Tracon Pharmaceuticals (NASDAQ:TCON)

Insider Ownership Percentage: 5.30%
Institutional Ownership Percentage: 30.98%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/3/2016	Ronald L Shazer	Insider	Sell	1,003	$7.48	$7,502.44
10/16/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	1,500	$9.90	$14,850.00
10/15/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	5,300	$10.16	$53,848.00
10/13/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	3,168	$10.01	$31,711.68
10/9/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	1,448	$10.01	$14,494.48
10/8/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	21,920	$10.10	$221,392.00
10/5/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	15,100	$10.08	$152,208.00
9/25/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	7,600	$12.13	$92,188.00
9/24/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	22,303	$12.99	$289,715.97
9/22/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	39,426	$14.02	$552,752.52
9/21/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	18,200	$14.48	$263,536.00
9/18/2015	Charles Theuer	CEO	Sell	10,000	$17.34	$173,400.00
9/18/2015	H Casey Logan	insider	Sell	5,000	$17.34	$86,700.00
9/17/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	42,344	$11.78	$498,812.32
9/14/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	60,038	$11.78	$707,247.64
9/10/2015	Charles Theuer	CEO	Sell	3,516	$12.00	$42,192.00
9/9/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	12,000	$10.71	$128,520.00
9/8/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	5,700	$10.47	$59,679.00
9/4/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	6,600	$10.48	$69,168.00
9/3/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	15,300	$10.51	$160,803.00
9/1/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	14,000	$10.42	$145,880.00
8/24/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	3,000	$11.00	$33,000.00
8/20/2015	Jafco Super V3 Investment Limi	major shareholder	Sell	10,683	$11.36	$121,358.88
8/18/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	11,174	$11.71	$130,847.54
8/13/2015	Jafco Super V3 Investment Limi	Major Shareholder	Sell	9,361	$11.60	$108,587.60
2/4/2015	M James Barrett	Major Shareholder	Buy	500,000	$10.00	$5,000,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for Tracon Pharmaceuticals (NASDAQ:TCON)

Date	Headline
	Biggest Movers in Manufacturing Stocks Now - MRUS AUPH NMBL TCON - Investorplace.com (NASDAQ:TCON) investorplace.com - September 29 at 7:32 PM
	TRACON Pharmaceutical (TCON) Offers Additional Detail on Janssen Licensing Agreement - StreetInsider.com (NASDAQ:TCON) www.streetinsider.com - September 29 at 7:32 PM
	Tracon Pharmaceuticals Licenses Two Potential Cancer Therapies (NASDAQ:TCON) www.sdbj.com - September 28 at 7:21 PM
	TRACON Pharmaceutical (TCON) Offers Additional Detail on Janssen Licensing Agreement (NASDAQ:TCON) www.streetinsider.com - September 28 at 7:21 PM
	TRACON gets US$5mln and licensing deal from Janssen (NASDAQ:TCON) www.proactiveinvestors.com - September 28 at 7:21 PM
	TRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equ (NASDAQ:TCON) biz.yahoo.com - September 28 at 7:21 PM
	TRACON Pharmaceutical (TCON) Enters Oncology Assets Licensing Collaboration with Janssen - StreetInsider.com (NASDAQ:TCON) www.streetinsider.com - September 28 at 10:39 AM
	TRACON Pharmaceuticals Announces a Strategic Licensing Collaboration for Two Janssen Oncology Assets and a $5 Million Equity Investment from Johnson & Johnson Innovation – JJDC, Inc. (NASDAQ:TCON) www.publicnow.com - September 28 at 10:39 AM
	Tracon Pharmaceuticals Incorporated (NASDAQ:TCON) Shorted Shares Increased By 3.45% - Post News (NASDAQ:TCON) www.kentuckypostnews.com - September 27 at 7:34 PM
	Shares Of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Expected To Hit $14 - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - September 23 at 10:12 AM
	Can Shares Of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Get To $14? - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - September 1 at 7:35 PM
	TRACON Pharmaceuticals to Present at Upcoming Investment Conferences (NASDAQ:TCON) finance.yahoo.com - September 1 at 10:49 AM
	TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - August 26 at 7:21 PM
	Stock Gapping Up Pre-Bell: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Post News (NASDAQ:TCON) www.kentuckypostnews.com - August 26 at 10:38 AM
	Stock Moving Up in Session: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Post News (NASDAQ:TCON) www.kentuckypostnews.com - August 23 at 12:14 PM
	TRACON PHARMACEUTICALS, INC. Financials (NASDAQ:TCON) finance.yahoo.com - August 18 at 7:56 PM
	TRACON Pharmaceuticals, Inc. :TCON-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:TCON) www.capitalcube.com - August 15 at 8:04 PM
	Trader's Recap: Ametek Inc. (NYSE:AME), TRACON Pharmaceuticals, Inc. (NASDAQ:TCON), ArcelorMittal SA (ADR ... - KC Register (NASDAQ:TCON) www.kcregister.com - August 13 at 10:30 AM
	Edited Transcript of TCON earnings conference call or presentation 10-Aug-16 8:30pm GMT (NASDAQ:TCON) finance.yahoo.com - August 11 at 8:18 PM
	TRACON PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:TCON) biz.yahoo.com - August 11 at 11:05 AM
	Tracon reports 2Q loss (NASDAQ:TCON) sg.finance.yahoo.com - August 10 at 8:17 PM
	TRACON Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:TCON) www.publicnow.com - August 10 at 8:17 PM
	Q2 2016 TRACON Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:TCON) biz.yahoo.com - August 10 at 10:52 AM
	ETF’s with exposure to TRACON Pharmaceuticals, Inc. : August 5, 2016 (NASDAQ:TCON) www.capitalcube.com - August 5 at 7:55 PM
	TRACON to Report Second Quarter 2016 Company Highlights and Financial Results on August 10, 2016 (NASDAQ:TCON) www.publicnow.com - August 3 at 8:06 PM
	TRACON PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TCON) biz.yahoo.com - July 29 at 4:03 PM
	Can Shares Of TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Hit $14? - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - July 29 at 10:49 AM
	Is $14 Price Target Attainable For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)? - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - July 23 at 11:31 AM
	Stock Up Nicely This Week: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON) telanaganapress.com - July 23 at 11:31 AM
	Equity Roundup: Stock Performance Focus on TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON) presstelegraph.com - July 20 at 8:45 PM
	Earnings Focus and Crowd Sourced Sentiment Review for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON) telanaganapress.com - July 19 at 8:43 AM
	Were Analysts Bearish TRACON Pharmaceuticals Inc (NASDAQ:TCON) This Week? - Consumer Eagle (NASDAQ:TCON) www.consumereagle.com - July 19 at 8:43 AM
	Shares Moving Down on the Week: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 17 at 10:43 AM
	TRACON Pharmaceuticals, Inc. (TCON) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:TCON) www.fiscalstandard.com - July 17 at 10:43 AM
	Shares Experiencing a Downtrend: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - TGP (NASDAQ:TCON) telanaganapress.com - July 16 at 10:54 AM
	Analyst Target and Average Rating Watch: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON) presstelegraph.com - July 14 at 8:01 PM
	TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 14 at 8:01 PM
	Strong Sell Calls For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) At 0 - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - July 14 at 8:01 PM
	TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:TCON) telanaganapress.com - July 12 at 12:04 PM
	Session Volatility Review for: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 12 at 12:04 PM
	Heightened Volatility Check on: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 8 at 7:42 PM
	Company Stock Focus for TRACON Pharmaceuticals, Inc. (NASDAQ:TCON): Which Way Will Shares Head? - Press Telegraph (NASDAQ:TCON) presstelegraph.com - July 8 at 7:42 PM
	Is $26 Within Reach For TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)? - Investor Newswire (NASDAQ:TCON) www.investornewswire.com - July 8 at 7:42 PM
	Broker Outlook For TRACON Pharmaceuticals, Inc. (TCON) - Fiscal Standard (NASDAQ:TCON) www.fiscalstandard.com - July 8 at 7:42 PM
	Increased Volatility Watch for: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 6 at 8:10 PM
	TRACON Pharmaceuticals Inc (NASDAQ:TCON)'s Company Shares Decreased 43.53% After High Volatility - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - July 6 at 8:10 PM
	Broker Outlook For The Week Ahead TRACON Pharmaceuticals, Inc. (TCON) - Fiscal Standard (NASDAQ:TCON) www.fiscalstandard.com - July 5 at 7:23 PM
	Shares Touching a Recent Low: TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) - Press Telegraph (NASDAQ:TCON) presstelegraph.com - July 5 at 7:23 PM
	Are Analysts Bullish TRACON Pharmaceuticals Inc (NASDAQ:TCON) After Last Week? - Press Telegraph (NASDAQ:TCON) presstelegraph.com - July 3 at 10:19 AM
	TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Earnings Glance and Target Price Review - Engelwood Daily (NASDAQ:TCON) www.engelwooddaily.com - June 30 at 7:54 PM